Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer Immunology, Immunotherapy : CII|June 1, 2015
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefitEleftheria A Anastasopoulou, Ioannis F Voutsas, Theodora Keramitsoglou, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|March 10, 2007
Combining immunological and molecular data to assess phylogenetic relations of some Greek Podarcis speciesEfstratios D Valakos, Andriani Kourkouli, Margarita Skopeliti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2013
Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID miceIoannis F Voutsas, Nikolaos Pistamaltzian, Marinos L Tsiatas, et al.
International Journal of Radiation Biology|January 15, 2013
Gamma-irradiation induces HER-2/neu overexpression in breast cancer cell lines and sensitivity to treatment with trastuzumabIoannis F Voutsas, Louisa G Mahaira, Katerina Fotopoulou, et al.
Cancer Immunology, Immunotherapy : CII|February 3, 2006
The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patientsMargarita Skopeliti, Ioannis F Voutsas, Persefoni Klimentzou, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
Ii-Key/HER-2/neu(776-790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumorsNectaria N Sotiriadou, Nikoletta L Kallinteris, Angelos D Gritzapis, et al.
Current Medicinal Chemistry|May 20, 2017
Prothymosin Alpha: An Alarmin and MorePinelopi Samara, Chrysoula-Evangelia Karachaliou, Kyriaki Ioannou, et al.
Current Medicinal Chemistry|November 18, 2021
Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro and In Vivo InvestigationAnastasios I Birmpilis, Panagiotis Vitsos, Ioannis V Kostopoulos, et al.
Pageof 3